Entyvio: Frequently Asked Questions Answered
What is Entyvio (vedolizumab)?
Vedolizumab, which is sold under the brand name of Entyvio, belongs to a class of drugs known as monoclonal antibodies. The medication works by blocking the action of some natural substances in the body. Entyvio is administered for the treatment of ulcerative colitis and Crohn’s disease. In these medical conditions, the body’s immune system attacks the healthy cells in the gut, which leads to a range of symptoms such as diarrhoea, abdominal pain and blood in the stool.
What are the uses of Entyvio?
Entyvio (vedolizumab) is a monoclonal antibody that is used as a prescription drug for the treatment of moderate or severe ulcerative colitis and severe Crohn’s disease. These conditions can cause adverse gut-related symptoms such as vomiting, nausea, diarrhoea, abdominal pain, and blood in the stool. Entyvio reduces the effect of certain symptoms that aggravate these conditions.